<!DOCTYPE html>
<html lang="en-us">
<head>
    <meta http-equiv="Content-Type" content="text/html" charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">

    <title>CoMCoR</title>
    <meta name="author" content="">
    <meta name="description" content="Comorbidities and colorectal cancer">
    <meta name="generator" content="Hugo 0.41" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=no">

    <link rel="shortcut icon" href="/hugo-sp-minimal/img/favicon.ico">

    <!-- Stylesheets -->
    <link rel="stylesheet" href="/hugo-sp-minimal/css/styles.css">
    <link rel="stylesheet" href="/hugo-sp-minimal/css/sp-minimal.css">
    
      <link rel="stylesheet" href="/hugo-sp-minimal/css/sp-minimal-simple.css">
    
    <link rel="stylesheet" href="//cdnjs.cloudflare.com/ajax/libs/highlight.js/8.3/styles/default.min.css">
</head>

<body><div class="wrapper">

<header class="text-center">
   <img src="/hugo-sp-minimal/img/logo.png" class="img-circle s200"> 

  
    <h1 class="border-bottom add-padding-bottom"><a href="/hugo-sp-minimal/">CoMCoR</a></h1>
  
	
  
    <h2 class="text-right add-padding-right">The impact of comorbidities on Cancer Prognosis and Survival: a Population-Based Evaluation</h2>
  

  
    <p class="text-right remove-margin-bottom add-padding-right">Comorbidities and colorectal cancer</p>
  
</header>





  
    
      <section>
      

<h2 id="the-impact-of-comorbidities-on-cancer-prognosis-and-survival-a-population-based-evaluation">The impact of comorbidities on Cancer Prognosis and Survival: a Population-Based Evaluation</h2>

<p>Recurrence and disease-free survival are usually analysed in clinical trials, enrolling healthier and younger cancer patients than the general cancer population, thus being unrepresentative for the real-world where comorbid elderly cancer patients are the group with higher cancer incidence rates. As part of the effort to evaluate real-world comparative effectiveness research and cancer survival outcomes, the cancer registries of Granada and Girona, identified all incident cases (n = 4,678) from five different cancer sites. Clinical information from patients diagnosed during the period 2010-2012 and follow-up until December 31st, 2016 was collected as part of a High-Resolution study (2013-Transcan project). Patients’ age at diagnosis, tumour stage, bio-molecular tumour characteristics, type of treatment and comorbidities were drawn from administrative and medical records.</p>

<p>The main objective of the proposal is to <strong>investigate the extent to which comorbidities influence cancer prognosis, survival, and treatment choices</strong>. We will analyse 1, 2, 3, and 5-year progression free survival, and overall survival of patients diagnosed with breast, colorectal, and lung cancers, skin melanoma and Non-Hodgkin lymphoma. Specifically, we will investigate:</p>

<ul>
<li><p>the response to the first treatment, and progression free survival after at least five years since diagnosis</p></li>

<li><p>the extent to which the presence of comorbidities is associated with clinical adherence to cancer treatment guidelines</p></li>

<li><p>the occurrence and type of the relapse</p></li>

<li><p>the association of cancer progression with patients’ and tumour characteristics, type of treatment and comorbidities.</p></li>
</ul>

<p><strong>The investigation will contribute to promote policy action aiming to reduce cancer survival disparities.</strong></p>

<hr />

<h2 id="about-us">About us</h2>

<h2 id="non-communicable-and-cancer-epidemiology-group-biomedical-research-institute-of-granada-ibs-granada"><strong>Non‐Communicable and Cancer Epidemiology Group, Biomedical Research Institute of Granada (ibs.Granada)</strong></h2>

<p>Carlos III Institute of Health, Grant/Award Number: CP17/002026</p>

<p>We are a team with a broad multidisciplinary background, leading cancer research in Spain and Europe.</p>

<p>We develop our work in the <a href="http://www.cancergranada.org"><strong>Granada Cancer Registry</strong></a>, at the <a href="http://www.easp.es/"><strong>Andalusian School of Public Health</strong></a>.</p>

<p><img src="images/logo_MALF.png" alt="" /></p>

<h3 id="miguel-ángel-luque-fernández"><strong>Miguel Ángel Luque Fernández</strong></h3>

<ul>
<li>Doctor con distinción europea y premio de doctorado en Epidemiología y Salud Pública por la Universidad de Granada.</li>
<li>Máster en Bioestadística, Universidad de Newcastle, Australia.</li>
<li>Máster en Epidemiología Aplicada de campo, Centro Nacional de Epidemiología, Instituto de Salud Carlos III.</li>
<li>Máster en Epidemiología y bioestadística, Universidad Libre de Bélgica.</li>
<li>Máster en Salud Pública y Gestión Sanitaria, Universidad de Granada.</li>
</ul>

<h4 id="other-affiliations">Other affiliations</h4>

<ul>
<li>Profesor honorifico de Epidemiología y Bioestadística en el departamento de Epidemiología de las enfermedades no contagiosas, Grupo de Supervivencia del Cáncer, London School of Hygiene &amp; Tropical Medicine.</li>
<li>Investigador asociado de la Universidad de Bruselas, en el departamento de Epidemiología y Bioestadística.</li>
<li>Científico visitante en el departamento de Epidemiología de la Harvard TH Chan School of Public Health.</li>
</ul>

<h3 id="img-src-images-tw-png-alt-twitter-style-width-20px-watzilei-http-www-twitter-com-watzilei"><img src="images/tw.png" alt="twitter" style="width: 20px;"/> <a href="http://www.twitter.com/watzilei">@watzilei</a></h3>

<h3 id="img-src-images-git-jpg-alt-git-style-width-20px-migariane-https-github-com-migariane"><img src="images/git.jpg" alt="git" style="width: 20px;"/>  <a href="https://github.com/migariane">@migariane</a></h3>

<h3 id="img-src-images-email-png-alt-email-style-width-20px-miguel-luque-easp-at-juntadeandalucia-es"><img src="images/email.png" alt="email" style="width: 20px;"/>  <em>miguel.luque.easp at juntadeandalucia.es</em></h3>

<hr />

<p><img src="images/logo_DRS.png" alt="" /></p>

<h3 id="daniel-redondo-sánchez"><strong>Daniel Redondo Sánchez</strong></h3>

<ul>
<li>Licenciado en Matemáticas. Universidad de Granada.</li>
<li>Experto Universitario en Epidemiología e Investigación Clínica. Universidad de Granada</li>
</ul>

<h3 id="img-src-images-tw-png-alt-twitter-style-width-20px-dredondosanchez-http-www-twitter-com-dredondosanchez"><img src="images/tw.png" alt="twitter" style="width: 20px;"/> <a href="http://www.twitter.com/dredondosanchez">@dredondosanchez</a></h3>

<h3 id="img-src-images-git-jpg-alt-git-style-width-20px-danielredondo-https-github-com-danielredondo"><img src="images/git.jpg" alt="git" style="width: 20px;"/>  <a href="https://github.com/danielredondo">@danielredondo</a></h3>

<h3 id="img-src-images-email-png-alt-email-style-width-20px-daniel-redondo-easp-at-juntadeandalucia-es"><img src="images/email.png" alt="email" style="width: 20px;"/>  <em>daniel.redondo.easp at juntadeandalucia.es</em></h3>

      </section> 
    
  


<footer>
  <p class="remove-margin-bottom add-padding-right">
  &copy; 2018 
    <a href="/hugo-sp-minimal/"></a>
  </p>

  <p class="remove-margin-bottom add-padding-right"><small>
    <a href="https://github.com/eueung/hugo-sp-minimal">Hugo SP-Minimal</a> Theme | 
    Based on <a href="https://github.com/orderedlist/minimal">Minimal</a>
  </small></p>    
</footer>


</div><script src="/hugo-sp-minimal/js/scale.fix.js"></script>
<script src="//cdnjs.cloudflare.com/ajax/libs/highlight.js/8.3/highlight.min.js"></script>

<script>hljs.initHighlightingOnLoad();</script>


</body></html>
